Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Total voting rights
-
FPC joins LEGIC Identsystems to enhance biometric security for the LEGIC Security Platform
-
Dividend payment ex-date of AS Ekspress Grupp
-
BW Offshore: Dividend information
-
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
-
BW Offshore: First quarter results 2025
-
Atos Group receives confirmatory offer from the French State to acquire part of its former Advanced Computing business
-
Vodafone Qatar selects Nokia in major network modernization deal to drive expanded 5G coverage, reliability, and services
-
WISeKey’s WISe.ART 3.0, One of the World’s First and Largest Web3 Marketplaces for Digital Art, Twins, NFTs, and Crypto Collectibles will be Presenting FABEN’s MLove at NFC Lisbon on June 5 on t
-
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
-
Start of Day Message
-
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
-
WISeKey to Present at Maxim Tech Conference “Discover the Innovations Reshaping Tomorrow” on June 3 at 8:30am ET
-
DNO Contemplates Hybrid Bond Issue
-
Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome
-
AVTL successfully completed IPO
-
The Evolution of the CFO: From Financial Steward to Strategic Visionary
-
WISeKey’s WISe.ART 3.0, One of the World’s First and Largest Web3 Marketplaces for Digital Art, Twins, NFTs, and Crypto Collectibles will be Presenting FABEN’s MLove at NFC Lisbon on June 5 on t
-
Ipsen S.A. - Initiation of the share buy-back program
-
Okeanis Eco Tankers Corp. – Ex Dividend Date
-
UPDATE: Texas Hemp Industry Urges Governor Abbott to Veto SB 3 in Emergency Press Conference
-
Tocexa Crypto Exchange Limited Secures SEC and MSB Licenses, Advancing Global Compliance Strategy
-
Crypto Lottery's Biggest Unclaimed Win: $211,992 Search Underway for Player ‘Supah Man’
-
Toronto’s Top Creators
-
HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting
-
Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
-
Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
-
TORRAS Personal Cooling with Coolify Series: A Tech-Driven Solution for Comfort, Wellness, and Women's Health
-
TORRAS Personal Cooling with Coolify Series: A Tech-Driven Solution for Comfort, Wellness, and Women's Health
-
Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AML
-
Cenovus Energy provides operations update on impact of Alberta wildfires
-
Digital assets usher in a golden age. Cryptocurrency will become the first choice for asset reserves in 2025. Fans Hash machines will lead industry innovation.
-
PXG Marks 5th Year of Women’s Golf Month with Expanded #SheGolfs Invitation to Play Amid Historic Surge in Women’s Golf Participation
-
KONTAKTUM (former Berger Kommunkation) launches SignalDesk to Power Europe’s Top Wellness Brands
-
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 Months with Individualized Cancer Vaccine TG4050
-
Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025
-
OFL Commemorates First Official Injured Workers’ Day and Demands Recognition Be Met with Justice
-
Camfil Releases 2024 Sustainability Report Emphasizing Transparency, Circularity, and Climate Action
-
After 40 Years, Ontario Finally Recognizes Injured Workers’ Day
-
Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO
-
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
-
EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
-
Mining Without Machines: ZA Miner Launches Seamless Cloud Solution for Daily Crypto Rewards
-
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
-
ZA Miner Launches An AI-Driven Mining Protocol Ensuring Users Earn the Highest Crypto Rewards
-
Breaking the Paycheck-to-Paycheck Cycle: Bitcoin Solaris Presale Phase 5 Ends in Hours—Mobile Mining App Nears Launch
-
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
-
StreetLeaf Plants its 10,000th Light in Advance of Hurricane Season
-
NIO Inc. Provides May 2025 Delivery Update
-
XPENG Announces Vehicle Delivery Results for May 2025
